Small dense LDL: An underestimated driver of atherosclerosis (Review)

Agnello F, Ingala S, Laterra G, Scalia L and Barbanti M: Novel and emerging LDL-C lowering strategies: A new era of dyslipidemia management. J Clin Med. 13:12512024. View Article : Google Scholar

Mukherjee D and Nissen SE: Lipoprotein (a) as a biomarker for cardiovascular diseases and potential new therapies to mitigate risk. Curr Vasc Pharmacol. 22:171–179. 2024. View Article : Google Scholar

German CA and Shapiro MD: Assessing atherosclerotic cardiovascular disease risk with advanced lipid testing: State of the science. Eur Cardiol. 15:e562020. View Article : Google Scholar

Antoniades C and West HW: ESC CVD Prevention Guidelines 2021: Improvements, controversies, and opportunities. Cardiovasc Res. 118:e17–e19. 2022. View Article : Google Scholar

McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, et al: 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC. Rev Esp Cardiol (Engl Ed). 75:5232022.

De Oliveira-Gomes D, Joshi PH, Peterson ED, Rohatgi A, Khera A and Navar AM: Apolipoprotein B: bridging the gap between evidence and clinical practice. Circulation. 150:62–79. 2024. View Article : Google Scholar

Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, Himmelfarb CD, Khera A, Lloyd-Jones D, McEvoy JW, et al: 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: Executive summary: A report of the American college of Cardiology/American heart association task force on clinical practice guidelines. J Am Coll Cardiol. 74:1376–1414. 2019. View Article : Google Scholar

Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE, et al: 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: A report of the American college of Cardiology/American heart association task force on clinical practice guidelines. Circulation. 139:e1082–e1143. 2019. View Article : Google Scholar

Akyol O, Yang CY, Woodside DG, Chiang HH, Chen CH and Gotto AM: Comparative analysis of atherogenic lipoproteins L5 and Lp(a) in atherosclerotic cardiovascular disease. Curr Atheroscler Rep. 26:317–329. 2024. View Article : Google Scholar

Proctor SD, Wang M, Vine DF and Raggi P: Predictive utility of remnant cholesterol in atherosclerotic cardiovascular disease. Curr Opin Cardiol. 39:300–307. 2024. View Article : Google Scholar

Attiq A, Afzal S, Ahmad W and Kandeel M: Hegemony of inflammation in atherosclerosis and coronary artery disease. Eur J Pharmacol. 966:1763382024. View Article : Google Scholar

Khosravi M, Sheikhnia F, Pashaei MR, Karimi-Dehkordi M and Alizadeh-Fanalou S: Association between small dense low-density lipoprotein and carotid intima-media thickness. J Cardiovasc Thorac Res. 16:202–210. 2024. View Article : Google Scholar

Benitez S, Puig N, Camps-Renom P and Sánchez-Quesada JL: Atherogenic circulating lipoproteins in ischemic stroke. Front Cardiovasc Med. 11:14703642024. View Article : Google Scholar

Wang J, Zhao X, Zhao Y, Jin R, Li Y, Wang J, Liu Y, Wu Z, Guo X and Tao L: Discordance of small dense LDL cholesterol beyond LDL cholesterol or non-HDL cholesterol and carotid plaque. JACC Asia. 5:1012–1028. 2025. View Article : Google Scholar

Luciani L, Pedrelli M and Parini P: Modification of lipoprotein metabolism and function driving atherogenesis in diabetes. Atherosclerosis. 394:1175452024. View Article : Google Scholar

Orekhov AN: We must abandon the Myth: Oxidized low-density lipoprotein is not a lipoprotein that plays a key role in atherogenesis. Curr Med Chem. 32:2899–2914. 2025. View Article : Google Scholar

Vedamurthy D, Sagheer U, Patel A, Singh G and Kalra D: Management of dyslipidemia in chronic kidney disease. Curr Cardiovasc Risk Rep. 19:102025. View Article : Google Scholar

Kim S and Subramanian S: Approach to lipid management in the patient with diabetes. J Clin Endocrinol Metab. 110:1740–1755. 2025. View Article : Google Scholar

Tomlinson B and Chan P: Exploring emerging pharmacotherapies for type 2 diabetes patients with hypertriglyceridemia. Expert Opin Pharmacother. 26:279–289. 2025. View Article : Google Scholar

Hirano T: Cinical significance of small dense low-density lipoprotein cholesterol measurement in type 2 diabetes. J Diabetes Investig. 16:370–383. 2025. View Article : Google Scholar

Hernando-Redondo J, Niño OC and Fitó M: Atherogenic low-density lipoprotein and cardiovascular risk. Curr Opin Lipidol. 36:8–13. 2025. View Article : Google Scholar

Konieczynska M, Natorska J, Ząbczyk M and Undas A: Lipoprotein(a) and thromboembolism: Current state of knowledge and unsolved issues. Arch Med Sci. 20:1770–1783. 2024.

Qiao YN, Zou YL and Guo SD: Low-density lipoprotein particles in atherosclerosis. Front Physiol. 13:9319312022. View Article : Google Scholar

Jin X, Yang S, Lu J and Wu M: Small, dense low-density lipoprotein-cholesterol and atherosclerosis: Relationship and therapeutic strategies. Front Cardiovasc Med. 8:8042142022. View Article : Google Scholar

Stanciulescu LA, Scafa-Udriste A and Dorobantu M: Exploring the association between low-density lipoprotein subfractions and major adverse cardiovascular outcomes-a comprehensive review. Int J Mol Sci. 24:66692023. View Article : Google Scholar

Nakayama A, Morita H, Sato T, Kawahara T, Takeda N, Kato S, Itoh H and Komuro I: Small dense low-density lipoprotein cholesterol is a potential marker for predicting laser treatment for retinopathy in diabetic patients. J Atheroscler Thromb. 29:678–691. 2022. View Article : Google Scholar

Piccirillo F, Mastroberardino S, Nusca A, Frau L, Guarino L, Napoli N, Ussia GP and Grigioni F: Novel antidiabetic agents and their effects on lipid profile: A single shot for several cardiovascular targets. Int J Mol Sci. 24:101642023. View Article : Google Scholar

Chary A, Tohidi M and Hedayati M: Association of LDL-cholesterol subfractions with cardiovascular disorders: A systematic review. BMC Cardiovasc Disord. 23:5332023. View Article : Google Scholar

Gluba-Sagr A, Olszewski R, Franczyk B, Młynarska E, Rysz-Górzyńska M, Rysz J, Surma S, Sohum S, Banach M and Toth PP: High-density lipoproteins. Part 2. Impact of disease states on functionality. Am J Prev Cardiol. 23:1010732025. View Article : Google Scholar

Orekhov A, Sukhorukov V and Melnichenko A: Is oxidized low-density lipoprotein a principal actor in atherogenesis? Curr Med Chem. 31:6909–6910. 2024. View Article : Google Scholar

Mosalmanzadeh N and Pence BD: Oxidized low-density lipoprotein and its role in immunometabolism. Int J Mol Sci. 25:113862024. View Article : Google Scholar

Jiang H, Zhou Y, Nabavi SM, Sahebkar A, Little PJ, Xu S, Weng J and Ge J: Mechanisms of oxidized LDL-mediated endothelial dysfunction and its consequences for the development of atherosclerosis. Front Cardiovasc Med. 9:9259232022. View Article : Google Scholar

Kloc M, Uosef A, Kubiak JZ and Ghobrial RM: Role of Macrophages and RhoA pathway in atherosclerosis. Int J Mol Sci. 22:2162020. View Article : Google Scholar

Farahi L, Sinha SK and Lusis AJ: Roles of macrophages in atherogenesis. Front Pharmacol. 12:7852202021. View Article : Google Scholar

Gruber EJ, Aygun AY and Leifer CA: Macrophage uptake of oxidized and acetylated low-density lipoproteins and generation of reactive oxygen species are regulated by linear stiffness of the growth surface. PLoS One. 16:e02607562021. View Article : Google Scholar

Malekmohammad K, Bezsonov EE and Rafieian-Kopaei M: Role of lipid accumulation and inflammation in atherosclerosis: Focus on molecular and cellular mechanisms. Front Cardiovasc Med. 8:7075292021. View Article : Google Scholar

Chakraborty S, Verma A, Garg R, Singh J and Verma H: Cardiometabolic risk factors associated with type 2 diabetes mellitus: A mechanistic Insight. Clin Med Insights Endocrinol Diabetes. 16:117955142312207802023. View Article : Google Scholar

Yanai H, Adachi H, Hakoshima M and Katsuyama H: Molecular biological and clinical understanding of the statin residual cardiovascular disease risk and peroxisome proliferator-activated receptor alpha agonists and ezetimibe for its treatment. Int J Mol Sci. 23:34182022. View Article : Google Scholar

He Q, Wang L, Fang Y, Liang M, Chen X, Hu R and Zhong J: Relationship of small dense low-density lipoprotein cholesterol level with pre-diabetes and newly detected type 2 diabetes. Sci Rep. 15:195002025. View Article : Google Scholar

Vekic J, Stromsnes K, Mazzalai S, Zeljkovic A, Rizzo M and Gambini J: Oxidative stress, atherogenic dyslipidemia, and cardiovascular risk. Biomedicines. 11:28972023. View Article : Google Scholar

Eichhorn T, Weiss R, Huber S, Ebeyer-Masotta M, Mostageer M, Emprechtinger R, Knabl L Sr, Knabl L, Würzner R and Weber V: Expression of tissue factor and platelet/leukocyte markers on extracellular vesicles reflect platelet-leukocyte interaction in severe COVID-19. Int J Mol Sci. 24:168862023. View Article : Google Scholar

Tsioufis P, Theofilis P, Tsioufis K and Tousoulis D: The impact of cytokines in coronary atherosclerotic plaque: Current therapeutic approaches. Int J Mol Sci. 23:159372022. View Article : Google Scholar

Sleutjes JAM, van Lennep JER, van der Woude CJ and de Vries AC: Thromboembolic and atherosclerotic cardiovascular events in inflammatory bowel disease: Epidemiology, pathogenesis and clinical management. Therap Adv Gastroenterol. 2021.1417562848211032126. 2021.

Hall AE, Jade D, Shaik F, Homer-Vanniasinkam S, Muench SP, Harrison MA and Ponnambalam S: Modified lipid particle recognition: A link between atherosclerosis and cancer? Biology (Basel). 14:6752025.

Therond P and Chapman MJ: Sphingosine-1-phosphate: Metabolism, transport, atheroprotection and effect of statin treatment. Curr Opin Lipidol. 33:199–207. 2022. View Article : Google Scholar

Miceli G, Basso MG, Pintus C, Pennacchio AR, Cocciola E, Cuffaro M, Profita M, Rizzo G and Tuttolomondo A: Molecular pathways of vulnerable carotid plaques at risk of ischemic stroke: A narrative review. Int J Mol Sci. 25:43512024. View Article : Google Scholar

Alonso-Herranz L, Albarrán-Juárez J and Bentzon JF: Mechanisms of fibrous cap formation in atherosclerosis. Front Cardiovasc Med. 10:12541142023. View Article : Google Scholar

Jebari-Benslaiman S, Galicia-García U, Larrea-Sebal A, Olaetxea JR, Alloza I, Vandenbroeck K, Benito-Vicente A and Martín C: Pathophysiology of Atherosclerosis. Int J Mol Sci. 23:33462022. View Article : Google Scholar

Islam MS, Wei P, Suzauddula M, Nime I, Feroz F, Acharjee M and Pan F: The interplay of factors in metabolic syndrome: Understanding its roots and complexity. Mol Med. 30:2792024. View Article : Google Scholar

Bays HE, Kirkpatrick CF, Maki KC, Toth PP, Morgan RT, Tondt J, Christensen SM, Dixon DL and Jacobson TA: Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the obesity medicine association and the national lipid association 2024. J Clin Lipidol. 18:e320–e350. 2024. View Article : Google Scholar

Jayaraman S, Pérez A, Miñambres I, Sánchez-Quesada JL and Gursky O: LDL binding to cell receptors and extracellular matrix is proatherogenic in obesity but improves after bariatric surgery. J Lipid Res. 64:1004512023. View Article : Google Scholar

Superko H and Garrett B: Small Dense LDL: Scientific background, clinical relevance, and recent evidence still a risk even with ‘Normal’ LDL-C Levels. Biomedicines. 10:8292022. View Article : Google Scholar

Manemann SM, Bielinski SJ, Moser ED, St Sauver JL, Takahashi PY, Roger VL, Olson JE, Chamberlain AM, Remaley AT, Decker PA, et al: Variability in lipid levels and risk for cardiovascular disease: An electronic health record-based population cohort study. J Am Heart Assoc. 12:e0276392023. View Article : Google Scholar

Cao X, Wang N, Yang M and Zhang C: Lipid accumulation and insulin resistance: Bridging metabolic dysfunction-associated fatty liver disease and chronic kidney disease. Int J Mol Sci. 26:69622025. View Article : Google Scholar

Seehusen KE, Remaley AT, Sampson M, Meeusen JW, Larson NB, Decker PA, Killian JM, Takahashi PY, Roger VL, Manemann SM, et al: Discordance between very low-density lipoprotein cholesterol and low-density lipoprotein cholesterol increases cardiovascular disease risk in a geographically defined cohort. J Am Heart Assoc. 13:e0318782024. View Article : Google Scholar

Farooq S, Generoso G, Bensenor IM, Santos RD, Jones SR, Moraes E, Blaha MJ, Toth PP, Lotufo PA, Staniak HL and Bittencourt MS: Low-density lipoprotein-cholesterol subfractions as predictors for coronary artery calcium incidence and progression - The Brazilian longitudinal study of Adult Health (ELSA - Brasil). Atherosclerosis. 403:1191712025. View Article : Google Scholar

Katsi V, Argyriou N, Fragoulis C and Tsioufis K: The role of Non-HDL cholesterol and apolipoprotein B in cardiovascular disease: A comprehensive review. J Cardiovasc Dev Dis. 12:2562025.

Huang J, Gu JX, Bao HZ, Li SS, Yao XQ, Yang M, Li Y, Zhang AM, Yin Y, Zhang N, et al: Elevated serum small dense low-density lipoprotein cholesterol may increase the risk and severity of coronary heart disease and predict cardiovascular events in patients with type 2 diabetes mellitus. Dis Markers. 2021:55970282021. View Article : Google Scholar

Deza S, Colina I, Beloqui O, Monreal JI, Martínez-Chávez E, Maroto-García J, Mugueta C, González A and Varo N: Evaluation of measured and calculated small dense low-density lipoprotein in capillary blood and association with the metabolic syndrome. Clin Chim Acta. 557:1178972024. View Article : Google Scholar

Stoicescu C, Vacarescu C and Cozma D: HDL function versus small dense LDL: Cardiovascular benefits and implications. J Clin Med. 14:49452025. View Article : Google Scholar

Płaczkowska S, Sołkiewicz K, Bednarz-Misa I and Kratz EM: Atherogenic plasma index or non-high-density lipoproteins as markers best reflecting age-related high concentrations of small dense low-density lipoproteins. Int J Mol Sci. 23:50892022. View Article : Google Scholar

Liou L and Kaptoge S: Association of small, dense LDL-cholesterol concentration and lipoprotein particle characteristics with coronary heart disease: A systematic review and meta-analysis. PLoS One. 15:e02419932020. View Article : Google Scholar

Qi Y, Liu J, Wang W, Wang M, Zhao F, Sun J, Liu J, Deng Q and Zhao D: High sdLDL cholesterol can be used to reclassify individuals with low cardiovascular risk for early intervention: Findings from the Chinese multi-provincial cohort study. J Atheroscler Thromb. 27:695–710. 2020. View Article : Google Scholar

Hsu SH, Jang MH, Torng PL and Su TC: Positive association between small dense low-density lipoprotein cholesterol concentration and biomarkers of inflammation, thrombosis, and prediabetes in non-diabetic adults. J Atheroscler Thromb. 26:624–635. 2019. View Article : Google Scholar

Liu Z, Xv Y, Liu X and Zhou X: Associations of systemic inflammatory markers with the risks of chronic heart failure: A case-control study. Clinics (Sao Paulo). 77:1000562022. View Article : Google Scholar

Imamura T, Hori M, Narang N, Ueno H and Kinugawa K: Prognostic implication of small dense LDL-cholesterol levels following acute coronary syndrome. Medicina (Kaunas). 59:1582023. View Article : Google Scholar

Bashir B, Schofield J, Downie P, France M, Ashcroft DM, Wright AK, Romeo S, Gouni-Berthold I, Maan A, Durrington PN and Soran H: Beyond LDL-C: Unravelling the residual atherosclerotic cardiovascular disease risk landscape-focus on hypertriglyceridaemia. Front Cardiovasc Med. 11:13891062024. View Article : Google Scholar

Auger N, Potter BJ, He S, Healy-Profitós J, Schnitzer ME and Paradis G: Maternal cardiovascular disease 3 decades after preterm birth longitudinal cohort study of pregnancy vascular disorders. Hypertension. 75:788–795. 2020. View Article : Google Scholar

Shelbaya K, Claggett B, Dorbala P, Skali H, Solomon SD, Matsushita K, Konety S, Mosley TH and Shah AM: Stages of valvular heart disease among older adults in the community: The atherosclerosis risk in communities study. Circulation. 147:638–649. 2023. View Article : Google Scholar

Jia XM, Sun C, Nambi V, Virani SS, Taffet G, Boerwinkle E, Bressler J, Ndumele C, Windham BG, de Lemos JA, et al: Midlife determinants of healthy cardiovascular aging: The Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis. 350:82–89. 2022. View Article : Google Scholar

Ivensky V, Zonga P, Dallaire G, Desbiens LC, Nadeau-Fredette AC, Rousseau G and Goupil R: Differences in antihypertensive medication prescription profiles between 2009 and 2021: A retrospective cohort study of CARTaGENE. Can J Kidney Health Dis. 11:205435812412347292024. View Article : Google Scholar

Bodoarca R, Yeung RO and Lau D: New diabetes guidelines: Impact on eligibility for sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in Canada. Can J Diabetes. 46:691–698. 2022. View Article : Google Scholar

Zhang P, Zhang Z, Li D, Han R, Li H, Ma J, Xu P, Qi Z, Liu L and Zhang A: Association of remnant cholesterol with intracranial atherosclerosis in community-based population: The ARIC study. J Stroke Cerebrovasc Dis. 32:1072932023. View Article : Google Scholar

Blaha MJ and DeFilippis AP: Multi-Ethnic Study of Atherosclerosis (MESA): JACC Focus Seminar 5/8. J Am Coll Cardiol. 77:3195–3216. 2021. View Article : Google Scholar

Wolska A, Sampson M, Zubirán R, Meeusen JW, Donato LJ, Jaffe AS and Remaley AT: An equation for estimating low-density lipoprotein-triglyceride content and its use for cardiovascular disease risk stratification. Front Cardiovasc Med. 11:14528692024. View Article : Google Scholar

Hussain A, Sun C, Selvin E, Nambi V, Coresh J, Jia X, Ballantyne CM and Hoogeveen RC: Triglyceride-rich lipoproteins, apolipoprotein C-III, angiopoietin-like protein 3, and cardiovascular events in older adults: Atherosclerosis Risk in Communities (ARIC) study. Eur J Prev Cardiol. 29:E53–E64. 2022. View Article : Google Scholar

Bruggen FHV and Diamond DM: Is targeting LDL-C levels below 70 mg/dL beneficial for cardiovascular and overall health? A critical examination of the evidence. J Clin Med. 14:35692025. View Article : Google Scholar

Ishii J, Kashiwabara K, Ozaki Y, Takahashi H, Kitagawa F, Nishimura H, Ishii H, Iimuro S, Kawai H, Muramatsu T, et al: Small dense low-density lipoprotein cholesterol and cardiovascular risk in statin-treated patients with coronary artery disease. J Atheroscler Thromb. 29:1458–1474. 2022. View Article : Google Scholar

Wang X, Wang L, Cao R, Yang X, Xiao W, Zhang Y and Ye P: Correlation between small and dense low-density lipoprotein cholesterol and cardiovascular events in Beijing community population. J Clin Hypertens (Greenwich). 23:345–351. 2021. View Article : Google Scholar

Chen S, Li Z, Li H, Zeng X, Yuan H and Li Y: Novel lipid biomarkers and ratios as risk predictors for premature coronary artery disease: A retrospective analysis of 2952 patients. J Clin Hypertens (Greenwich). 25:1172–1184. 2023. View Article : Google Scholar

Borén J, Chapman MJ, Krauss RM, Packard CJ, Bentzon JF, Binder CJ, Daemen MJ, Demer LL, Hegele RA, Nicholls SJ, et al: Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: A consensus statement from the European atherosclerosis society consensus panel. Eur Heart J. 41:2313–2330. 2020. View Article : Google Scholar

Cesaro A, Acerbo V, Scialla F, Scherillo G, De Michele G, Panico D, Porcelli G, de Sio V, Capolongo A, Sperlongano S, et al: Role of LipoprotEin(a) in CardiovascuLar diseases and premature acute coronary syndromes (RELACS study): Impact of Lipoprotein(a) levels on the premature coronary event and the severity of coronary artery disease. Nutr Metab Cardiovasc Dis. 35:1038432025. View Article : Google Scholar

Chary A and Hedayati M: Review of laboratory methods to determine HDL and LDL subclasses and their clinical importance. Rev Cardiovasc Med. 23:1472022. View Article : Google Scholar

Ye Y, Markussen B, Engelsen SB and Khakimov B: The quality, uniqueness, and causality of NMR-based prediction models for low-density lipoprotein cholesterol subfractions in human blood plasma. Comput Biol Med. 184:1093792025. View Article : Google Scholar

Berisha H, Hattab R, Comi L, Giglione C, Migliaccio S and Magni P: Nutrition and lifestyle interventions in managing dyslipidemia and cardiometabolic risk. Nutrients. 17:7762025. View Article : Google Scholar

Packard CJ: Remnants, LDL, and the quantification of lipoprotein-associated risk in atherosclerotic cardiovascular disease. Curr Atheroscler Rep. 24:133–142. 2022. View Article : Google Scholar

Cole J, Zubirán R, Wolska A, Jialal I and Remaley AT: Use of apolipoprotein B in the Era of precision medicine: time for a paradigm change? J Clin Med. 12:57372023. View Article : Google Scholar

Kounatidis D, Vallianou NG, Poulaki A, Evangelopoulos A, Panagopoulos F, Stratigou T, Geladari E, Karampela I and Dalamaga M: ApoB100 and atherosclerosis: What's New in the 21st Century? Metabolites. 14:1232024. View Article : Google Scholar

Gugliucci A: The chylomicron saga: Time to focus on postprandial metabolism. Front Endocrinol (Lausanne). 14:13228692024. View Article : Google Scholar

Araujo G, Valencia LM, Martin-Ozimek A, Soto Y and Proctor SD: Atherosclerosis: From lipid-lowering and anti-inflammatory therapies to targeting arterial retention of ApoB-containing lipoproteins. Front Immunol. 16:14858012025. View Article : Google Scholar

Lorey MB, Öörni K and Kovanen PT: Modified lipoproteins induce arterial wall inflammation during atherogenesis. Front Cardiovasc Med. 9:8415452022. View Article : Google Scholar

Bekbossynova M, Ivanova-Razumova T, Kali A, Sailybayeva A, Khamitov S, Daniyarova G, Akzholova K and Saliev T: Apolipoprotein B and glycemic dysregulation: New predictors of type 2 diabetes in high-cardiovascular-risk populations. J Pers Med. 15:1632025. View Article : Google Scholar

Zhu X, Chen Y, Zhu M and Hu J: The relationship between small dense low-density lipoprotein cholesterol and metabolic syndrome. Diabetes Metab Syndr Obes. 17:1523–1532. 2024. View Article : Google Scholar

Fosam A, Bansal R, Ramanathan A, Sarcone C, Iyer I, Murthy M, Remaley AT and Muniyappa R: Lipoprotein insulin resistance index: A simple, accurate method for assessing insulin resistance in South Asians. J Endocr Soc. 7:bvac1892023. View Article : Google Scholar

Natale F, Franzese R, Marotta L, Mollo N, Solimene A, Luisi E, Gentile C, Loffredo FS, Golino P and Cimmino G: Evolving concepts of the SCORE system: Subtracting cholesterol from risk estimation: A way for a healthy longevity? Life (Basel). 14:6792024.

Vekic J, Zeljkovic A, Stefanovic A, Bogavac-Stanojevic N, Ilias I, Silva-Nunes J, Stoian AP, Janez A and Rizzo M: Novel pharmaceutical and nutraceutical-based approaches for cardiovascular diseases prevention targeting atherogenic small dense LDL. Pharmaceutics. 14:8252022. View Article : Google Scholar

Kirkpatrick CF, Sikand G, Petersen KS, Anderson CAM, Aspry KE, Bolick JP, Kris-Etherton PM and Maki KC: Nutrition interventions for adults with dyslipidemia: A clinical perspective from the National lipid association. J Clin Lipidol. 17:428–451. 2023. View Article : Google Scholar

Candás-Estébanez B, Fernández-Cidón B, Corbella E, Tebé C, Fanlo-Maresma M, Esteve-Luque V, Salas-Salvadó J, Fitó M, Riera-Mestre A, Ros E and Pintó X: The impact of the mediterranean diet and lifestyle intervention on lipoprotein subclass profiles among metabolic syndrome patients: Findings of a randomized controlled trial. Int J Mol Sci. 25:13382024. View Article : Google Scholar

Falkenhain K, Roach LA, McCreary S, McArthur E, Weiss EJ, Francois ME and Little JP: Effect of carbohydrate-restricted dietary interventions on LDL particle size and number in adults in the context of weight loss or weight maintenance: A systematic review and meta-analysis. Am J Clin Nutr. 114:1455–1466. 2021. View Article : Google Scholar

Zubirán R, Neufeld EB, Dasseux A, Remaley AT and Sorokin AV: Recent advances in targeted management of inflammation in atherosclerosis: A narrative review. Cardiol Ther. 13:465–491. 2024. View Article : Google Scholar

Yang BF, Ma X, Yang L, Bian G, Qiao B, Lu H, Wang Z, Zhang T and Cheng Y: Trends and prospects of low-density lipoprotein cholesterol in stroke: A bibliometric analysis. Cureus. 16:e694922024.

Wilson DP and Patel M: Statin use in children and adolescents-dos, don'ts and practical tips. Curr Atheroscler Rep. 27:162024. View Article : Google Scholar

Ueki Y, Itagaki T and Kuwahara K: Lipid-lowering therapy and coronary plaque regression. J Atheroscler Thromb. 31:1479–1495. 2024. View Article : Google Scholar

Soleimani H, Mousavi A, Shojaei S, Tavakoli K, Salabat D, Farahani Rad F, Askari MK, Nelson J, Ruzieh M and Hosseini K: Safety and effectiveness of high-intensity statins versus low/moderate-intensity statins plus ezetimibe in patients with atherosclerotic cardiovascular disease for reaching LDL-C goals: A systematic review and meta-analysis. Clin Cardiol. 47:e243342024. View Article : Google Scholar

Zeng WW and Tomlinson B: Statin alternatives for the treatment of hypercholesterolemia-a safety evaluation. Expert Opin Drug Saf. 24:17–24. 2025. View Article : Google Scholar

Wierzbicki AS: Advances in the pharmacological management of hyperlipidemia through the use of combination therapies. Expert Opin Pharmacother. 26:157–165. 2025. View Article : Google Scholar

Canfora I and Pierno S: Hypertriglyceridemia therapy: Past, present and future perspectives. Int J Mol Sci. 25:97272024. View Article : Google Scholar

Fuior EV, Zvintzou E, Filippatos T, Giannatou K, Mparnia V, Simionescu M, Gafencu AV and Kypreos KE: Peroxisome proliferator-activated receptor α in lipoprotein metabolism and atherosclerotic cardiovascular disease. Biomedicines. 11:26962023. View Article : Google Scholar

Rubins HB, Robins SJ and Collins D: The veterans affairs high-density lipoprotein intervention trial: Baseline characteristics of normocholesterolemic men with coronary artery disease and low levels of high-density lipoprotein cholesterol. Am J Cardiol. 78:572–575. 1996. View Article : Google Scholar

Keech A, Simes RJ, Barter P, Best J, Scott R, Taskinen MR, Forder P, Pillai A, Davis T, Glasziou P, et al: Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): Randomised controlled trial. Lancet. 366:1849–1861. 2005. View Article : Google Scholar

Nesti L, Tricò D, Mengozzi A and Natali A: Rethinking pioglitazone as a cardioprotective agent: A new perspective on an overlooked drug. Cardiovasc Diabetol. 20:1092021. View Article : Google Scholar

Shao L, Zhi A, Li M, Zhang Y, Jiang S, Zhang J, Yang K, Yang E, Zhu X, Cheng Y and Sun Y: Exploring the impact of niacin intake on cardiovascular outcomes: A comprehensive analysis using NHANES Data (2003–2018). Rev Cardiovasc Med. 25:4102024. View Article : Google Scholar

Sherratt SCR, Libby P, Budoff MJ, Bhatt DL and Mason RP: Role of omega-3 fatty acids in cardiovascular disease: The debate continues. Curr Atheroscler Rep. 25:1–17. 2023. View Article : Google Scholar

Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB, Doyle RT Jr, Juliano RA, Jiao L, Granowitz C, et al: Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. N Engl J Med. 380:11–22. 2019. View Article : Google Scholar

Parhofer KG, Chapman MJ and Nordestgaard BG: Efficacy and safety of icosapent ethyl in hypertriglyceridaemia: A recap. Eur Heart J Suppl. 22 (Supplement_J):J21–J33. 2020. View Article : Google Scholar

Basha A and Ramakrishnan S: Lipid clinical trials with special reference to Indian population. Indian Heart J. 76 (Suppl 1):S130–S137. 2024. View Article : Google Scholar

Kaur G, Mason RP, Steg PG and Bhatt DL: Omega-3 fatty acids for cardiovascular event lowering. Eur J Prev Cardiol. 31:1005–1014. 2024. View Article : Google Scholar

Machado NM, Oliveira MVB, Quesada K, Haber JFDS, José Tofano R, Rubira CJ, Zutin TLM, Direito R, Pereira ESBM, de Oliveira CM, et al: Assessing omega-3 therapy and its cardiovascular benefits: What about icosapent ethyl? A systematic review and meta-analysis. Pharmaceuticals (Basel). 18:6012025. View Article : Google Scholar

Abduljabbar MH: PCSK9 inhibitors: Focus on evolocumab and its impact on atherosclerosis progression. Pharmaceuticals (Basel). 17:15812024. View Article : Google Scholar

Giordano S, Ielapi J, Salerno N, Cersosimo A, Lucchino A, Laschera A, Canino G, Di Costanzo A, De Rosa S, Torella D and Sorrentino S: Rationale for early administration of PCSK9 inhibitors in acute coronary syndrome. Rev Cardiovasc Med. 25:3742024. View Article : Google Scholar

Schonck WAM, Stroes ESG, Hovingh GK and Reeskamp LF: Long-term efficacy and tolerability of PCSK9 targeted therapy: A review of the literature. Drugs. 84:165–178. 2024. View Article : Google Scholar

Gareri C, Polimeni A, Giordano S, Tammè L, Curcio A and Indolfi C: Antisense oligonucleotides and small interfering RNA for the treatment of dyslipidemias. J Clin Med. 11:38842022. View Article : Google Scholar

Sharif A, Mamo J, Lam V, Al-Salami H, Mooranian A, Watts GF, Clarnette R, Luna G and Takechi R: The therapeutic potential of probucol and probucol analogues in neurodegenerative diseases. Transl Neurodegener. 13:62024. View Article : Google Scholar

Yamashita S, Arai H, Bujo H, Masuda D, Ohama T, Ishibashi T, Yanagi K, Doi Y, Nakagawa S, Yamashiro K, et al: Probucol trial for secondary prevention of atherosclerotic events in patients with coronary heart disease (PROSPECTIVE). J Atheroscler Thromb. 28:103–123. 2021. View Article : Google Scholar

Lang L, Zhang J, Zheng D and Gao H: Probucol will become a new model for treating cerebral infarction with a high risk of hemorrhage: A narrative review. Brain Circ. 9:222–227. 2023. View Article : Google Scholar

Adili R, Hawley M and Holinstat M: Regulation of platelet function and thrombosis by omega-3 and omega-6 polyunsaturated fatty acids. Prostaglandins Other Lipid Mediat. 139:10–18. 2018. View Article : Google Scholar

Siniscalchi C, Basaglia M, Meschi T, Imbalzano E, Futura Bernardi F, Perrella A, Trama U, Passannanti A, Di Micco P and Schiano C: Low LDL-cholesterol and hemorrhagic risk: Mechanistic insights and clinical perspectives. Int J Mol Sci. 26:56122025. View Article : Google Scholar

Kohli-Lynch CN, Thanassoulis G, Moran AE and Sniderman AD: The clinical utility of apoB versus LDL-C/non-HDL-C. Clin Chim Acta. 508:103–108. 2020. View Article : Google Scholar

Chait A, Eckel RH, Vrablik M and Zambon A: Lipid-lowering in diabetes: An update. Atherosclerosis. 394:1173132024. View Article : Google Scholar

Yang Z, Deng Q, Hao Y, Yang N, Han L, Jia P, Zhou P, Hao Y, Wang Z, Zhao W, et al: Effectiveness of treat-to-target cholesterol-lowering interventions on cardiovascular disease and all-cause mortality risk in the community-dwelling population: A target trial emulation. Nat Commun. 15:99222024. View Article : Google Scholar

Virani SS, Aspry K, Dixon DL, Ferdinand KC, Heidenreich PA, Jackson EJ, Jacobson TA, McAlister JL, Neff DR, Gulati M and Ballantyne CM: The importance of low-density lipoprotein cholesterol measurement and control as performance measures: A joint clinical perspective from the national lipid association and the American Society for preventive cardiology. J Clin Lipidol. 17:208–218. 2023. View Article : Google Scholar

Alsadig REK and Morsi AN: Comparison of multiple equations for low-density lipoprotein cholesterol calculation against the direct homogeneous method. J Lipid Atheroscler. 13:348–357. 2024. View Article : Google Scholar

Meng JB, An ZJ and Jiang CS: Machine learning-based prediction of LDL cholesterol: Performance evaluation and validation. PeerJ. 13:e192482025. View Article : Google Scholar

Ahn J and Kim B: Application of generative artificial intelligence in dyslipidemia care. J Lipid Atheroscler. 14:77–93. 2025. View Article : Google Scholar

Han J, Kim Y, Kang HJ, Seo J, Choi H, Kim M, Kee G, Park S, Ko S, Jung H, et al: Predicting low density lipoprotein cholesterol target attainment using machine learning in patients with coronary artery disease receiving moderate-dose statin therapy. Sci Rep. 15:53462025. View Article : Google Scholar

Olmo RF, Cortez G, Toro MM, Sandín M, Mora J, Oterino A, Bailen MC, Quiles-Granado J, Urbiola P, Ruz LF and Cordero A: A machine learning algorithm for the identification elevated Lp(a) in patients with, or high-risk of having, coronary heart disease. Int J Cardiol. 418:1326122025. View Article : Google Scholar

Tavaglione F, Marafioti G, Romeo S and Jamialahmadi O: Machine learning reveals the contribution of lipoproteins to liver triglyceride content and inflammation. J Clin Endocrinol Metab. 110:218–227. 2025. View Article : Google Scholar

Sezer S, Oter A, Ersoz B, Topcuoglu C, İbrahim Bulbul H, Sagiroglu S, Akin M and Yilmaz G: Explainable artificial intelligence for LDL cholesterol prediction and classification. Clin Biochem. 130:1107912024. View Article : Google Scholar

Jalepalli SK, Gupta P, Dekker ALAJ, Bermejo I and Kar S: Development and validation of multicentre study on novel Artificial intelligence-based cardiovascular risk score (AICVD). Fam Med Community Health. 12 (Suppl 1):e0023402024. View Article : Google Scholar

Mohanty PK, Francis SAJ, Barik RK, Roy DS and Saikia MJ: Leveraging shapley additive explanations for feature selection in ensemble models for diabetes prediction. Bioengineering (Basel). 11:12152024. View Article : Google Scholar

Bezsonov E, Chernyi N, Saruhanyan M, Shimchenko D, Bondar N, Gavrilova D, Baig MS and Malogolovkin A: Gene therapy approaches for atherosclerosis focusing on targeting lipid metabolism and inflammation. Int J Mol Sci. 26:69502025. View Article : Google Scholar

Kaya Kaçar H, Kaçar OF and Avery A: Diet quality and caloric accuracy in ai-generated diet plans: A comparative study across chatbots. Nutrients. 17:2062025. View Article : Google Scholar

Kassem H, Beevi AA, Basheer S, Lutfi G, Cheikh Ismail L and Papandreou D: Investigation and assessment of AI's role in nutrition-an updated narrative review of the evidence. Nutrients. 17:1902025. View Article : Google Scholar

Wang X, Sun Z, Xue H and An R: Artificial intelligence applications to personalized dietary recommendations: A systematic review. Healthcare (Basel). 13:14172025. View Article : Google Scholar

Lin A, Manral N, McElhinney P, Killekar A, Matsumoto H, Kwiecinski J, Pieszko K, Razipour A, Grodecki K, Park C, et al: Deep learning-enabled coronary CT angiography for plaque and stenosis quantification and cardiac risk prediction: An international multicentre study. Lancet Digit Health. 4:e256–e265. 2022. View Article : Google Scholar

Zhang LJ, Chen Q, Zhou F, Xie G, Tang CX, Gao X, Zhang Y, Yin X and Xu H: Advances in Artificial intelligence-assisted coronary computed tomographic angiography for atherosclerotic plaque characterization. Rev Cardiovasc Med. 25:272024. View Article : Google Scholar

Chong PL, Vaigeshwari V, Mohammed Reyasudin BK, Noor Hidayah BRA, Tatchanaamoorti P, Yeow JA and Kong FY: Integrating artificial intelligence in healthcare: Applications, challenges, and future directions. Future Sci OA. 11:25275052025. View Article : Google Scholar

Młynarska E, Bojdo K, Frankenstein H, Kustosik N, Mstowska W, Przybylak A, Rysz J and Franczyk B: Nanotechnology and artificial intelligence in dyslipidemia management-cardiovascular disease: Advances, challenges, and future perspectives. J Clin Med. 14:8872025. View Article : Google Scholar

Cross JL, Choma MA and Onofrey JA: Bias in medical AI: Implications for clinical decision-making. PLOS Digital Health. 3:e00006512024. View Article : Google Scholar

Almogadwy B and Alqarafi A: Fused federated learning framework for secure and decentralized patient monitoring in healthcare 5.0 using IoMT. Sci Rep. 15:242632025. View Article : Google Scholar

Pati S, Kumar S, Varma A, Edwards B, Lu C, Qu L, Wang JJ, Lakshminarayanan A, Wang SH, Sheller MJ, et al: Privacy preservation for federated learning in health care. Patterns (N Y). 5:1009742024. View Article : Google Scholar

Katsoulakis E, Wang Q, Wu H, Shahriyari L, Fletcher R, Liu J, Achenie L, Liu H, Jackson P, Xiao Y, et al: Digital twins for health: A scoping review. NPJ Digit Med. 7:772024. View Article : Google Scholar

Vallée A: Digital twin for healthcare systems. Front Digit Health. 5:12530502023. View Article : Google Scholar

Marey A, Arjmand P, Alerab ADS, Eslami MJ, Saad AM, Sanchez N and Umair M: Explainability, transparency and black box challenges of AI in radiology: Impact on patient care in cardiovascular radiology. Egypt J Radiol Nucl Med. 55:1832024. View Article : Google Scholar

Nagaraj D, Khandelwal P, Steyaert S and Gevaert O: Augmenting digital twins with federated learning in medicine. Lancet Digit Health. 5:e251–e253. 2023. View Article : Google Scholar

Kolaszyńska O and Lorkowski J: Artificial intelligence in cardiology and atherosclerosis in the context of precision medicine: A scoping review. Appl Bionics Biomech. 2024:29912432024. View Article : Google Scholar

Saether JC, Klevjer M, Giskeødegård GF, Bathen TF, Gigante B, Gjære S, Myhra M, Vesterbekkmo EK, Wiseth R, Madssen E and Bye A: Small LDL subfractions are associated with coronary atherosclerosis despite no differences in conventional lipids. Physiol Genomics. 55:16–26. 2023. View Article : Google Scholar

Licari C, Tenori L, Di Cesare F, Luchinat C, Giusti B, Kura A, De Cario R, Inzitari D, Piccardi B, Nesi M, et al: Nuclear magnetic resonance-based metabolomics to predict early and late adverse outcomes in ischemic stroke treated with intravenous thrombolysis. J Proteome Res. 22:16–25. 2023. View Article : Google Scholar

Kanonidou C: Small dense low-density lipoprotein: Analytical review. Clin Chim Acta. 520:172–178. 2021. View Article : Google Scholar

Wong ND, Budoff MJ, Ferdinand K, Graham IM, Michos ED, Reddy T, Shapiro MD and Toth PP: Atherosclerotic cardiovascular disease risk assessment: An American Society for Preventive Cardiology clinical practice statement. Am J Prev Cardiol. 10:1003352022. View Article : Google Scholar

Srichawla BS, Gopal D and Moonis M: Association of statin therapy with functional outcomes and survival in intracerebral and subarachnoid hemorrhage. Neurol Int. 17:272025. View Article : Google Scholar

Hafiz A, Aljohani S, Kutbi H, Fatani N, Alkhathran L, Alyaqub M, Alhamed MS, Alhaqbani AO, Alhadlaq AA, Alsalman MA, et al: Statin use and major adverse cardiovascular events among patients with ischemic heart diseases: A multi-center retrospective study. J Clin Med. 14:9082025. View Article : Google Scholar

Liao PC, Chen MS, Jhou MJ, Chen TC, Yang CT and Lu CJ: Integrating health data-driven machine learning algorithms to evaluate risk factors of early stage hypertension at different levels of HDL and LDL Cholesterol. Diagnostics (Basel). 12:19652022. View Article : Google Scholar

Masson W, Corral P, Nogueira JP and Lavalle-Cobo A: Applicability of artificial intelligence in the field of clinical lipidology: A narrative review. J Lipid Atheroscler. 13:111–121. 2024. View Article : Google Scholar

Guo CL, Han X, Zhang T, Zhang H, Li X, Zhou X, Feng S, Tao T, Yin C and Xia J: Lipidomic analyses reveal potential biomarkers for predicting death and heart failure after acute myocardial infarction. Clin Chim Acta. 562:1198922024. View Article : Google Scholar

Girona J, Soler O, Samino S, Junza A, Martínez-Micaelo N, García-Altares M, Ràfols P, Esteban Y, Yanes O, Correig X, et al: Lipidomics reveals myocardial lipid composition in a murine model of insulin resistance induced by a high-fat diet. Int J Mol Sci. 25:27022024. View Article : Google Scholar

Wittenhofer P, Kiesewetter L, Schmitz OJ and Meckelmann SW: Investigation of the cholesterol biosynthesis by heart-cut liquid chromatography and mass spectrometric detection. J Chromatogr A. 1738:4654752024. View Article : Google Scholar

Castro C, Harshfield EL, Butterworth AS, Wood AM, Koulman A and Griffin JL: A lipidomic dataset for epidemiological studies of acute myocardial infarction. Data Brief. 57:1109252024. View Article : Google Scholar

Gadgil MD, Herrington DM, Singh SK, Kandula NR and Kanaya AM: Association of lipoprotein subfractions with incidence of type 2 diabetes among five US race and ethnic groups: The mediators of atherosclerosis in South Asians living in America (MASALA) and multi-ethnic study of atherosclerosis (MESA). Diabetes Res Clin Pract. 204:1109262023. View Article : Google Scholar

Lomonosova A, Gognieva D, Suvorov A, Silantyev A, Abasheva A, Vasina Y, Abdullaev M, Nartova A, Eroshchenko N, Kazakova V, et al: The blood plasma lipidomic profile in atherosclerosis of the brachiocephalic arteries. Biomedicines. 12:12792024. View Article : Google Scholar

Miao GH, Pechlaner R, Fiehn O, Malloy KM, Zhang Y, Umans JG, Mayr M, Willeit J, Kiechl S and Zhao J: Longitudinal lipidomic signature of coronary heart disease in American Indian people. J Am Heart Assoc. 13:e0318252024. View Article : Google Scholar

Wang SJ, Han Y, Liu R, Hou M, Neumann D, Zhang J, Wang F, Li Y, Zhao X, Schianchi F, et al: Glycolysis-mediated activation of v-ATPase by nicotinamide mononucleotide ameliorates lipid-induced cardiomyopathy by repressing the CD36-TLR4 Axis. Circ Res. 134:505–525. 2024. View Article : Google Scholar

Lui DTW and Tan KCB: High-density lipoprotein in diabetes: Structural and functional relevance. J Diabetes Investig. 15:805–816. 2024. View Article : Google Scholar

Hirano T, Satoh N and Ito Y: Specific increase in small dense low-density lipoprotein-cholesterol levels beyond triglycerides in patients with diabetes: Implications for cardiovascular risk of MAFLD. J Atheroscler Thromb. 31:36–47. 2024. View Article : Google Scholar